A method of diagnosis or prognosis of multiple sclerosis development, comprising the step of measuring in a sample of nucleic acid for the presence of at least one polymorphism in a gene selected from the group of consisting of ferroportin (FPN1) gene, transferrin (TF) gene, hepcidin (HEPC) gene, coagulation factor XIII (FXIII) gene, metalloproteinase-12 (MMP12) gene and haemocromatosis (HFE) gene.
WO2012123785 (A1). GENE POLYMORPHISMS IN MULTIPLE SCLEROSIS
ZAMBONI, Paolo;GEMMATI, Donato
2012
Abstract
A method of diagnosis or prognosis of multiple sclerosis development, comprising the step of measuring in a sample of nucleic acid for the presence of at least one polymorphism in a gene selected from the group of consisting of ferroportin (FPN1) gene, transferrin (TF) gene, hepcidin (HEPC) gene, coagulation factor XIII (FXIII) gene, metalloproteinase-12 (MMP12) gene and haemocromatosis (HFE) gene.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
